Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126464592 | 12646459 | 2 | F | 2016 | 20160809 | 20160812 | 20160920 | PER | US-009507513-1608USA005841 | MERCK | 0.00 | F | Y | 0.00000 | 20160920 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126464592 | 12646459 | 1 | PS | INTRON A | INTERFERON ALFA-2B | 1 | Subcutaneous | 1.7 ML (17MU), EVERY MONDAY, WEDNESDAY AND FRIDAY FOR 48 WEEKS | L041049 | 103132 | 1.7 | ML | POWDER FOR INJECTION | QOD | |||||
| 126464592 | 12646459 | 2 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK, QPM | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126464592 | 12646459 | 1 | Skin cancer |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126464592 | 12646459 | Alopecia | |
| 126464592 | 12646459 | Headache | |
| 126464592 | 12646459 | Product use issue | |
| 126464592 | 12646459 | Productive cough | |
| 126464592 | 12646459 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126464592 | 12646459 | 1 | 201602 | 0 |